Evidence map›Paper›PMID 23053990›Full record

ArticleMolecular biology reports2012

Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats.

Hong-Bo Jin, Yong-Bin Yang, Ying-Li Song, Yong-chun Zhang, Yu-Rong Li

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Research progress of quercetin in cardiovascular disease.Frontiers in cardiovascular medicine · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Potential Implications of Quercetin and its Derivatives in Cardioprotection.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hong-Bo JinDepartment of Physiology, Harbin Medical University, 194 Xuefu Rd., Nangang District, Harbin, 150081, China.
Yong-Bin Yang
Ying-Li Song
Yong-chun Zhang
Yu-Rong Li
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial ischemia and reperfusion (MI/R) is associated with an intense inflammatory reaction, which may lead to myocyte injury. In this study, we investigated the effect of quercetin, an inhibitor of c-Jun N-terminal kinase on ischemia/reperfusion injury in isolated rat hearts. Rat models of MI/R were induced by coronary occlusion followed by reperfusion, treatment of rats with quercetin (1.0 mg/kg, i.v.) induced a significant reduction of infarct volume and improvements in baseline hemodynamic abnormalities (P < 0.05). Quercetin treatment also attenuated the expression of both TNF-alpha (TNF-α) and interleukin-10 (IL-10) and lowered the serum levels of inflammatory cytokine (P < 0.05). These findings suggested that quercetin treatment significantly attenuated MI/R injury primarily through anti-inflammatory effects.

Indexed as

AnimalsGene Expression RegulationHemodynamicsInterleukin-10MaleMyocardial InfarctionMyocardial Reperfusion InjuryMyocardiumProtective AgentsQuercetinRatsRats, Sprague-DawleyRNA, MessengerTumor Necrosis Factor-alphaInterleukin-10Protective AgentsQuercetinRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID23053990
OpenAlexW1965574611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.